Hospital Corporation of China Past Earnings Performance
Past criteria checks 2/6
Hospital of China's earnings have been declining at an average annual rate of -7.9%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been growing at an average rate of 32.1% per year. Hospital of China's return on equity is 28.5%, and it has net margins of 9.2%.
Key information
-7.9%
Earnings growth rate
-7.9%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 32.1% |
| Return on equity | 28.5% |
| Net Margin | 9.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
We Think Hospital Corporation of China's (HKG:3869) Profit Is Only A Baseline For What They Can Achieve
Apr 29
Hospital Corporation of China Limited (HKG:3869) Stock Rockets 33% But Many Are Still Ignoring The Company
Jun 30Hospital Corporation of China (HKG:3869) Hasn't Managed To Accelerate Its Returns
May 17Does Hospital Corporation of China (HKG:3869) Have A Healthy Balance Sheet?
Apr 12Would Shareholders Who Purchased Hospital Corporation of China's (HKG:3869) Stock Three Years Be Happy With The Share price Today?
Mar 08Should You Be Impressed By Hospital Corporation of China's (HKG:3869) Returns on Capital?
Jan 14Hospital Corporation of China (HKG:3869) Takes On Some Risk With Its Use Of Debt
Dec 10Revenue & Expenses Breakdown
How Hospital Corporation of China makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,428 | 131 | 132 | 0 |
| 30 Sep 23 | 1,374 | 102 | 121 | 0 |
| 30 Jun 23 | 1,320 | 73 | 110 | 0 |
| 31 Mar 23 | 1,231 | -204 | 103 | 0 |
| 31 Dec 22 | 1,143 | -481 | 96 | 0 |
| 30 Sep 22 | 998 | -424 | 104 | 0 |
| 30 Jun 22 | 854 | -367 | 112 | 0 |
| 31 Mar 22 | 687 | -324 | 105 | 0 |
| 31 Dec 21 | 520 | -281 | 98 | 0 |
| 30 Sep 21 | 473 | -245 | 71 | 0 |
| 30 Jun 21 | 426 | -210 | 44 | 0 |
| 31 Mar 21 | 412 | -307 | 48 | 0 |
| 31 Dec 20 | 399 | -404 | 52 | 0 |
| 30 Sep 20 | 391 | -435 | 56 | 0 |
| 30 Jun 20 | 383 | -467 | 60 | 0 |
| 31 Mar 20 | 397 | -158 | 62 | 0 |
| 31 Dec 19 | 411 | 151 | 65 | 0 |
| 30 Sep 19 | 414 | 110 | 64 | 0 |
| 30 Jun 19 | 418 | 70 | 64 | 0 |
| 31 Mar 19 | 401 | 10 | 64 | 0 |
| 31 Dec 18 | 384 | -50 | 64 | 0 |
| 30 Jun 18 | 235 | -53 | 58 | 0 |
| 31 Mar 18 | 192 | -40 | 56 | 0 |
| 31 Dec 17 | 149 | -27 | 54 | 0 |
| 30 Jun 17 | 143 | -5 | 50 | 0 |
| 31 Mar 17 | 137 | 9 | 38 | 0 |
| 31 Dec 16 | 131 | 23 | 26 | 0 |
| 30 Sep 16 | 160 | 34 | 26 | 0 |
| 31 Dec 15 | 143 | 51 | 13 | 0 |
| 31 Dec 14 | 28 | 2 | 9 | 0 |
Quality Earnings: 3869 has a large one-off loss of CN¥136.2M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 3869 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3869 has become profitable over the past 5 years, growing earnings by -7.9% per year.
Accelerating Growth: 3869 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 3869 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (7.8%).
Return on Equity
High ROE: Whilst 3869's Return on Equity (28.47%) is high, this metric is skewed due to their high level of debt.